Brief Title
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
Official Title
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue (PGSRT): a Randomized Clinical Trial
Brief Summary
This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis as a therapeutic modality in a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common morbidity of oral cancer therapy, namely speech and swallowing function in a population of patients with T1/T2 tumors of the tongue who are not currently routinely recommended for a palatal augmentation prosthesis.
Study Type
Interventional
Primary Outcome
Word intelligibility
Secondary Outcome
Sentence intelligibility
Condition
Tongue Neoplasms
Intervention
Palatal Augmentation Prosthesis (PAP)
Study Arms / Comparison Groups
Prosthesis + Articulation Therapy
Description: This arm will receive a palatal augmentation prosthesis with standard articulation therapy, and is the study arm.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
40
Start Date
January 2, 2018
Completion Date
June 2024
Primary Completion Date
January 2024
Eligibility Criteria
Inclusion Criteria: - Patients with a new diagnosis of a T1/T2 tongue cancer Exclusion Criteria: - Patients with recurrent disease - Patients with a history of prior head and neck radiation therapy - Patients who lack adequate maxillary dentition to support a palatal augmentation prosthesis
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Stephanie M Munz, DDS, 734 936-8289, [email protected]
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT02584270
Organization ID
HUM00093723.1
Responsible Party
Principal Investigator
Study Sponsor
University of Michigan
Study Sponsor
Stephanie M Munz, DDS, Principal Investigator, University of Michigan
Verification Date
February 2022